Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
39.39
-0.17 (-0.43%)
At close: Dec 20, 2024, 4:00 PM
39.64
+0.25 (0.63%)
After-hours: Dec 20, 2024, 7:58 PM EST
Moderna Revenue
Moderna had revenue of $1.86B in the quarter ending September 30, 2024, with 1.69% growth. This brings the company's revenue in the last twelve months to $5.08B, down -44.29% year-over-year. In the year 2023, Moderna had annual revenue of $6.85B, down -64.45%.
Revenue (ttm)
$5.08B
Revenue Growth
-44.29%
P/S Ratio
2.97
Revenue / Employee
$907,321
Employees
5,600
Market Cap
15.16B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Molina Healthcare | 37.54B |
| Fresenius Medical Care AG | 21.46B |
| Baxter International | 15.06B |
| Viatris | 15.05B |
| ICON Public Limited Company | 8.31B |
| Avantor | 6.82B |
| Hologic | 4.03B |
| Align Technology | 3.96B |
MRNA News
- 8 days ago - Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped. - Barrons
- 9 days ago - SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate - PRNewsWire
- 10 days ago - mRNA Vaccines and Therapeutics Industry Forecast to Generate Over $72 Billion in Revenues by 2032 - Breakdown by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region - GlobeNewsWire
- 12 days ago - Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline - PRNewsWire
- 13 days ago - mRNA Therapeutics Market Size to Hit USD 48.65 Billion by 2032 due to Advances in Cancer Treatment and Expanding mRNA Vaccine Applications | Research by SNS Insider - GlobeNewsWire
- 16 days ago - Moderna, Inc. (MRNA) Piper Sandler 36th Annual Healthcare Conference (Transcript) - Seeking Alpha
- 16 days ago - Moderna, Inc. (MRNA) 7th Annual Evercore ISI HealthCONx Conference - (Transcript) - Seeking Alpha
- 17 days ago - 20 stocks likely to lag the S&P 500 over the next year — for this one reason - Market Watch